These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32315971)

  • 1. Targeting tumor-associated macrophages in head and neck squamous cell carcinoma.
    Li B; Ren M; Zhou X; Han Q; Cheng L
    Oral Oncol; 2020 Jul; 106():104723. PubMed ID: 32315971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells.
    Yin X; Han S; Song C; Zou H; Wei Z; Xu W; Ran J; Tang C; Wang Y; Cai Y; Hu Q; Han W
    Cell Oncol (Dordr); 2019 Aug; 42(4):459-475. PubMed ID: 31001733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of
    Zhang P; Zhao Y; Xia X; Mei S; Huang Y; Zhu Y; Yu S; Chen X
    Oncoimmunology; 2023; 12(1):2203073. PubMed ID: 37089448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of CD68
    Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
    Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response.
    Tanagala KKK; Morin-Baxter J; Carvajal R; Cheema M; Dubey S; Nakagawa H; Yoon A; Cheng YL; Taylor A; Nickerson J; Mintz A; Momen-Heravi F
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
    Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma.
    Chen L; Wan SC; Mao L; Huang CF; Bu LL; Sun ZJ
    Cancer Immunol Immunother; 2023 Jun; 72(6):1647-1660. PubMed ID: 36586012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-regulated macrophage type 2 differentiation promotes immunosuppression in laryngeal squamous cell carcinoma.
    Zhang P; Zhang Y; Wang L; Lou W
    Life Sci; 2021 Feb; 267():118798. PubMed ID: 33220295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
    Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of immune cell infiltration in head and neck squamous carcinoma.
    Liang B; Tao Y; Wang T
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANXA3-Rich Exosomes Derived from Tumor-Associated Macrophages Regulate Ferroptosis and Lymphatic Metastasis of Laryngeal Squamous Cell Carcinoma.
    Xu L; Li W; Liu D; Cao J; Ge J; Liu X; Wang Y; Teng Y; Liu P; Guo X; He C; Liu M; Tian L
    Cancer Immunol Res; 2024 May; 12(5):614-630. PubMed ID: 38393971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prospects of nanotherapeutic approaches for targeting tumor-associated macrophages in oral cancer.
    Bhattacharya D; Sakhare K; Narayan KP; Banerjee R
    Nanomedicine; 2021 Jun; 34():102371. PubMed ID: 33662592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages in head and neck squamous cell carcinoma: A bibliometric analysis.
    Liang S; Wang J; Ma Z; Yu M; Gong ZP
    Medicine (Baltimore); 2023 Dec; 102(50):e36649. PubMed ID: 38115315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPP1
    Wu J; Shen Y; Zeng G; Liang Y; Liao G
    Cancer Gene Ther; 2024 Feb; 31(2):311-321. PubMed ID: 38052857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Macrophages-Enriched Head and Neck Tumor Spheroid Model to Study Foslip
    Francois A; Dirheimer L; Chateau A; Lassalle HP; Yakavets I; Bezdetnaya L
    Int J Nanomedicine; 2023; 18():6545-6562. PubMed ID: 37965282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.
    Mehraj U; Qayoom H; Mir MA
    Breast Cancer; 2021 May; 28(3):539-555. PubMed ID: 33661479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.
    Almangush A; Leivo I; Mäkitie AA
    Acta Otolaryngol; 2020 Mar; 140(3):246-248. PubMed ID: 32022615
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers.
    Suzuki S; Ogawa T; Sano R; Takahara T; Inukai D; Akira S; Tsuchida H; Yoshikawa K; Ueda R; Tsuzuki T
    Cancer Sci; 2020 Jun; 111(6):1943-1957. PubMed ID: 32304268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.